All research papers

Neuroendocrine Tumor Diagnosis and Management: ⁶⁸Ga-DOTATATE PET/CT.

Radiation Exposure to the Personnel Performing Robotic Arm-Assisted Positron Emission Tomography/Computed Tomography-Guided Biopsies.

Toward in vivo dosimetry in external beam radiotherapy using x-ray acoustic computed tomography: A soft-tissue phantom study validation.

A simple method to account for skin dose enhancement during treatment planning of VMAT treatments of patients in contact with immobilization equipment.

Evaluation and verification of the QFix Encompass TM couch insert for intracranial stereotactic radiosurgery.

Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches.

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With ¹⁷⁷Lu-Dotatate in the Phase III NETTER-1 Trial.

First online real-time evaluation of motion-induced 4D dose errors during radiotherapy delivery.

Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors.

Immobilization versus no immobilization for pelvic external beam radiotherapy.

[¹⁷⁷Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.

Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy.

Dosimetry and Treatment Descriptions Using the First Completely Automated Stereotactic Intracranial Radiosurgery Rotating Gamma Ray Unit in America.

The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes.

Is eye lens dosimetry needed in nuclear medicine?

Impact of ⁶⁸Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis.

Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice.

A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.

Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.

Deep Inspiration Breath Hold: Techniques and Advantages for Cardiac Sparing During Breast Cancer Irradiation.

Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations.

Monitoring frequency of intra-fraction patient motion using the ExacTrac system for LINAC-based SRS treatments.

Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study.

Evaluation of an Anti-HER2 Nanobody Labeled with ²²⁵Ac for Targeted α-Particle Therapy of Cancer.

Prospective observational study of ¹⁷⁷Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity.

Results and adverse events of personalized peptide receptor radionuclide therapy with ⁹⁰Yttrium and ¹⁷⁷Lutetium in 1048 patients with neuroendocrine neoplasms.

A comparative study of three small-field detectors for patient specific stereotactic arc dosimetry.

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.

Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile.

Immobilization and image-guidance methods for radiation therapy of limb extremity soft tissue sarcomas: Results of a multi-institutional survey.

Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with ²²⁵Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control.

Global comparison of targeted alpha vs targeted beta therapy for cancer: In vitro, in vivo and clinical trials.

High dose-per-pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use.

Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.

Comparison of complexity metrics for multi-institutional evaluations of treatment plans in radiotherapy.

Development of ²²⁵Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences.

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth.

Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.

Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.

Robustness of VMAT and 3DCRT plans toward setup errors in radiation therapy of locally advanced left-sided breast cancer with DIBH.

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.

Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.

Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia.

First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment.

Minimal mask immobilization with optical surface guidance for head and neck radiotherapy.

⁶⁸Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

Three-dimensional printer-generated patient-specific phantom for artificial in vivo dosimetry in radiotherapy quality assurance.

Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?

Eye lens dosimetry and the study on radiation cataract in interventional cardiologists.

An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy.

PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.

Procedures for the GMP-Compliant Production and Quality Control of [¹⁸F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.

Clinical Translation and First In-Human Use of [⁴⁴Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer.

Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.

Dosimetric evaluation of a commercial proton spot scanning Monte-Carlo dose algorithm: comparisons against measurements and simulations.

Targeted alpha therapy of mCRPC: Dosimetry estimate of ²¹³Bismuth-PSMA-617.

Somatostatin Receptor Antagonists for Imaging and Therapy.

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.

Online Adaptive Radiation Therapy: Implementation of a New Process of Care.